On May 25th, Astellas announces its intended decision to transfer its manufacturing plant and business based in Meppel, the Netherlands to Delpharm. The definitive agreement will be executed after completing works council consultation and local legal and regulatory requirements.
On February 17th, Delpharm finalized the acquisition of Carelide manufacturing site specialized in infusion bags, located in France.
A leading CDMO
Drug developer and Contract manufacturer. With its plants network, Delpharm is in the Top 5 CDMOs Worldwide.
Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.
Development & Regulation
A team of experts to support new pharmaceutical products.
Management ownership 100%
Turnover billion €
World Top 5
Delpharm is able to support your microsphere projects with development from scratch to commercial manufacturing through IMP (Investigational Medicinal Product) manufacturing.
Prefilled syringesWith Delpharm Leiden development center and Tours experts, we can support you in the development and manufacture of prefilled syringes. We have the capacity to produce between 25 and 30 million syringes a year in sizes ranging from 1ml to 50ml.
Regulatory affairsA full team dedicated to support you in the long term or for emergency needs.